261 related articles for article (PubMed ID: 31531840)
1. A comprehensive catalogue of EQ-5D scores in chronic disease: results of a systematic review.
Van Wilder L; Rammant E; Clays E; Devleesschauwer B; Pauwels N; De Smedt D
Qual Life Res; 2019 Dec; 28(12):3153-3161. PubMed ID: 31531840
[TBL] [Abstract][Full Text] [Related]
2. A systematic literature review to compare quality of life in psoriasis with other chronic diseases using EQ-5D-derived utility values.
Møller AH; Erntoft S; Vinding GR; Jemec GB
Patient Relat Outcome Meas; 2015; 6():167-77. PubMed ID: 26185476
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in rheumatoid arthritis: Systematic review and meta-analysis of EuroQoL (EQ-5D) utility scores from Asia.
Haridoss M; Bagepally BS; Natarajan M
Int J Rheum Dis; 2021 Mar; 24(3):314-326. PubMed ID: 33486900
[TBL] [Abstract][Full Text] [Related]
4. The quality of life in Chinese population with chronic non-communicable diseases according to EQ-5D-3L: a systematic review.
Zhou T; Guan H; Yao J; Xiong X; Ma A
Qual Life Res; 2018 Nov; 27(11):2799-2814. PubMed ID: 29980994
[TBL] [Abstract][Full Text] [Related]
5. Extent of Exacerbation of Chronic Health Conditions by Visual Impairment in Terms of Health-Related Quality of Life.
Park SJ; Ahn S; Woo SJ; Park KH
JAMA Ophthalmol; 2015 Nov; 133(11):1267-75. PubMed ID: 26379209
[TBL] [Abstract][Full Text] [Related]
6. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
[TBL] [Abstract][Full Text] [Related]
7. Catalogue of EQ-5D scores for the United Kingdom.
Sullivan PW; Slejko JF; Sculpher MJ; Ghushchyan V
Med Decis Making; 2011; 31(6):800-4. PubMed ID: 21422468
[TBL] [Abstract][Full Text] [Related]
8. Relative importance of the EQ-5D five dimensions among patients with chronic diseases in South Korea - a comparison with the general population preference weights.
Hong J
Health Qual Life Outcomes; 2018 Aug; 16(1):159. PubMed ID: 30075726
[TBL] [Abstract][Full Text] [Related]
9. [Assessment of health-related quality of life in psoriasis patients in Hungary].
Poór AK; Sárdy M; Cserni T; Brodszky V; Holló P; Gulácsi L; Remenyik É; Szegedi A; Rencz F; Péntek M
Orv Hetil; 2018 May; 159(21):837-846. PubMed ID: 29779387
[TBL] [Abstract][Full Text] [Related]
10. Preference-Based EQ-5D index scores for chronic conditions in the United States.
Sullivan PW; Ghushchyan V
Med Decis Making; 2006; 26(4):410-20. PubMed ID: 16855129
[TBL] [Abstract][Full Text] [Related]
11. EQ-5D Scores for Diabetes-Related Comorbidities.
Sullivan PW; Ghushchyan VH
Value Health; 2016 Dec; 19(8):1002-1008. PubMed ID: 27987626
[TBL] [Abstract][Full Text] [Related]
12. Health state utility values measured using the EuroQol 5-dimensions questionnaire in adults with chronic hepatitis C: a systematic literature review and meta-analysis.
Buchanan-Hughes AM; Buti M; Hanman K; Langford B; Wright M; Eddowes LA
Qual Life Res; 2019 Feb; 28(2):297-319. PubMed ID: 30225787
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in Parkinson's disease: systematic review and meta-analysis of EuroQol (EQ-5D) utility scores.
Bhanupriya R; Haridoss M; Lakshmi GS; Bagepally BS
Qual Life Res; 2024 Jul; 33(7):1781-1793. PubMed ID: 38581635
[TBL] [Abstract][Full Text] [Related]
14. EQ-5D-Derived Health State Utility Values in Hematologic Malignancies: A Catalog of 796 Utilities Based on a Systematic Review.
Golicki D; Jaśkowiak K; Wójcik A; Młyńczak K; Dobrowolska I; Gawrońska A; Basak G; Snarski E; Hołownia-Voloskova M; Jakubczyk M; Niewada M
Value Health; 2020 Jul; 23(7):953-968. PubMed ID: 32762998
[TBL] [Abstract][Full Text] [Related]
15. Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions.
Langelaan M; de Boer MR; van Nispen RM; Wouters B; Moll AC; van Rens GH
Ophthalmic Epidemiol; 2007; 14(3):119-26. PubMed ID: 17613846
[TBL] [Abstract][Full Text] [Related]
16. EQ-5D studies in cardiovascular diseases in eight Central and Eastern European countries: a systematic review of the literature.
Batóg P; Rencz F; Péntek M; Gulácsi L; Filipiak KJ; Prevolnik Rupel V; Simon J; Brodszky V; Baji P; Závada J; Petrova G; Rotar A; Golicki D
Kardiol Pol; 2018; 76(5):860-870. PubMed ID: 29350378
[TBL] [Abstract][Full Text] [Related]
17. Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population.
Jalkanen K; Aarnio E; Lavikainen P; Jauhonen HM; Enlund H; Martikainen J
Health Qual Life Outcomes; 2019 Jul; 17(1):117. PubMed ID: 31286982
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
[TBL] [Abstract][Full Text] [Related]
19. Health-Related Quality of Life in Patients With Different Diseases Measured With the EQ-5D-5L: A Systematic Review.
Zhou T; Guan H; Wang L; Zhang Y; Rui M; Ma A
Front Public Health; 2021; 9():675523. PubMed ID: 34268287
[No Abstract] [Full Text] [Related]
20. General population norms for the EQ-5D-3 L in Norway: comparison of postal and web surveys.
Stavem K; Augestad LA; Kristiansen IS; Rand K
Health Qual Life Outcomes; 2018 Oct; 16(1):204. PubMed ID: 30340499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
